A former director of the Centers for Disease Control and Prevention (CDC) has called for science and trustworthy information to be at the forefront of the development and approval of vaccines against covid-19. President Donald Trump has repeatedly said that a vaccine could be approved before the...
Vaccine 1. Introduction As the world struggles to control the COVID-19 pandemic, some researchers have proposed a bold agenda: using a ‘challenge study’ to deliberately infect individuals in order to accelerate vaccine development [1]. In the UK, a challenge study is already underway using re...
Gene-based vaccine platforms based on viral vectors, DNA, and RNA, have shown promising results encompassing both humoral and cell-mediated immune responses in previous studies, supporting their implementation for COVID-19 vaccine development. In fact, the U.S. Food and Drug Administration (FDA) ...
BEIJING, Jan. 1 (Xinhua) -- China optimized its COVID-19 strategy in a planned, science-based approach to cope with the changing situation of the pandemic, which is characterized by weakened pathogenicity. The shift of the strategy is to manage COVID-19 with measures designed for combating ...
That was based on results of Pfizer's clinical trial and an analysis of the potential risks. An independent FDA analysis considered both Pfizer's finding that its vaccine is 91 percent effective at preventing COVID in children ages 5 to 11 as well as the risks of both severe illness and ...
As states and countries throughout the world begin to relax social distancing restrictions and begin reengaging with day-to-day life, there are growing concerns that a second and more deadly wave of COVID-19 cases could occur. The concerns regarding a second wave of infection is based on dat...
Quantifying the impact of misinformation and vaccine-skeptical content on Facebook 量化Facebook 上虚假信息和疫苗怀疑内容的影响 (导读 小天)美国新冠疫苗接种率低下,主要收到社交媒体上虚假信息的影响。本研究评估了 2021 年推出首批 COVID-19 疫苗期间在 Faceboo...
Coronavirus Disease 2019 (COVID-19) has been the most severe public health challenge in this century. Two years after its emergence, the rapid development and deployment of effective COVID-19 vaccines have successfully controlled this pandemic and greatl
Concerns related to the readiness or robustness of evidence for application to policy are neither new nor unique to COVID-19. Terms such as ‘evidence-based policy’ have long been used to apply research to major decisions in government, institutions, schools and businesses28. The lack of conse...
In the last decade Open Science principles have been successfully advocated for and are being slowly adopted in different research communities. In response to the COVID-19 pandemic many publishers and researchers have sped up their adoption of Open Scien